Besremi Interactions
There are 448 drugs known to interact with Besremi (ropeginterferon alfa-2b), along with 10 disease interactions. Of the total drug interactions, 38 are major, and 410 are moderate.
- View all 448 medications that may interact with Besremi
- View Besremi disease interactions (10)
Most frequently checked interactions
View interaction reports for Besremi (ropeginterferon alfa-2b) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Allegra (fexofenadine)
- amitriptyline
- aspirin
- atorvastatin
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- boswellia / cholecalciferol / glucosamine
- bupropion
- cannabis
- Carafate (sucralfate)
- celecoxib
- Centrum Silver (multivitamin with minerals)
- codeine / guaifenesin
- Crestor (rosuvastatin)
- Cytomel (liothyronine)
- Dexilant (dexlansoprazole)
- diclofenac
- diltiazem
- Diltiazem Hydrochloride XR (diltiazem)
- Eliquis (apixaban)
- Exelderm (sulconazole topical)
- gabapentin
- hydrochlorothiazide
- Metoprolol Succinate ER (metoprolol)
- oxycodone
- Tylenol (acetaminophen)
Besremi disease interactions
There are 10 disease interactions with Besremi (ropeginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- hepatic dysfunction
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- colitis
- diabetes mellitus
- myelosuppression
Report options
QR code containing a link to this page
More about Besremi (ropeginterferon alfa-2b)
- Besremi consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic interferons
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
